Abstract
Calcium is a crucial regulator of many physiological processes such as cell growth, division, differentiation, cell death and apoptosis. In this study, we examined the effect of cGMP on agonist-induced [Ca2+]i transient in isolated rat aortic endothelial cells. 100 μM ATP was applied to the cells bathed in a Ca2+-free physiological solution to induce a [Ca2+]i transient that was caused by Ca2+ release from intracellular stores. cGMP, which was applied after [Ca2+]i reached its peak level, accelerated the falling phase of [Ca2+]i transient. Pre-treatment of the cells with CPA abolished the accelerating effect of cGMP on the falling phase of [Ca2+]i transient. The effect of cGMP was reversed by KT5823, a highly specific inhibitor of protein kinase G. Taken together, these data suggest that cGMP may reduce [Ca2+]i level by promoting Ca2+ uptake through sarcoplasmic/endoplasmic reticulum ATPase and that the effect of cGMP may be mediated by protein kinase G.
Original language | English |
---|---|
Pages (from-to) | 2019-2028 |
Number of pages | 10 |
Journal | Life Sciences |
Volume | 73 |
Issue number | 16 |
DOIs | |
Publication status | Published - 5 Sept 2003 |
Scopus Subject Areas
- General Biochemistry,Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics(all)
User-Defined Keywords
- cGMP
- Endothelial cells
- PKG
- SERCA